Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib

BACKGROUND: It is not clear whether tumor marker responses can predict survival during sorafenib treatment in hepatocellular carcinoma (HCC). We investigated whether the α-fetoprotein (AFP) response is associated with survival in patients with advanced HCC treated with sorafenib. METHODS: We retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sangheun, Kim, Beom Kyung, Kim, Seung Up, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918283/
https://www.ncbi.nlm.nih.gov/pubmed/27508193
http://dx.doi.org/10.2147/JHC.S79353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918283/
https://www.ncbi.nlm.nih.gov/pubmed/27508193
http://dx.doi.org/10.2147/JHC.S79353

Ejemplares similares